Patrick Carry
Concepts (440)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Scoliosis | 13 | 2026 | 223 | 3.400 |
Why?
| | Autoimmunity | 11 | 2026 | 926 | 2.920 |
Why?
| | DNA Methylation | 10 | 2026 | 681 | 2.820 |
Why?
| | Islets of Langerhans | 8 | 2026 | 833 | 2.580 |
Why?
| | Diabetes Mellitus, Type 1 | 14 | 2026 | 3890 | 1.760 |
Why?
| | Acetabulum | 17 | 2024 | 111 | 1.570 |
Why?
| | Hip Dislocation, Congenital | 11 | 2023 | 41 | 1.520 |
Why?
| | Brain Concussion | 10 | 2026 | 640 | 1.180 |
Why?
| | Hip Dislocation | 10 | 2025 | 53 | 1.100 |
Why?
| | Humeral Fractures | 8 | 2022 | 46 | 1.090 |
Why?
| | Adolescent | 73 | 2026 | 22428 | 1.090 |
Why?
| | Return to Sport | 9 | 2026 | 117 | 1.070 |
Why?
| | Spinal Fusion | 6 | 2022 | 260 | 1.040 |
Why?
| | Athletic Injuries | 10 | 2026 | 569 | 1.020 |
Why?
| | Epigenesis, Genetic | 5 | 2026 | 684 | 0.990 |
Why?
| | Fractures, Bone | 8 | 2023 | 414 | 0.980 |
Why?
| | Osteotomy | 12 | 2025 | 127 | 0.960 |
Why?
| | Child | 70 | 2026 | 22633 | 0.960 |
Why?
| | Orthopedic Procedures | 10 | 2020 | 243 | 0.930 |
Why?
| | Seroconversion | 2 | 2026 | 49 | 0.900 |
Why?
| | Disease Progression | 6 | 2026 | 2847 | 0.850 |
Why?
| | Hip Joint | 11 | 2022 | 172 | 0.830 |
Why?
| | Genome-Wide Association Study | 4 | 2024 | 1406 | 0.760 |
Why?
| | Vitamin D | 1 | 2026 | 400 | 0.740 |
Why?
| | Orthopedics | 1 | 2025 | 169 | 0.740 |
Why?
| | Child, Preschool | 27 | 2026 | 11787 | 0.730 |
Why?
| | Kyphosis | 1 | 2022 | 37 | 0.730 |
Why?
| | Propensity Score | 3 | 2023 | 367 | 0.720 |
Why?
| | Blood Loss, Surgical | 3 | 2021 | 112 | 0.700 |
Why?
| | Ultrasonic Therapy | 1 | 2021 | 16 | 0.690 |
Why?
| | Patient Selection | 2 | 2025 | 719 | 0.690 |
Why?
| | Radiography | 21 | 2021 | 844 | 0.680 |
Why?
| | Humans | 120 | 2026 | 144759 | 0.680 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 6 | 2019 | 192 | 0.660 |
Why?
| | Autoantibodies | 4 | 2026 | 1501 | 0.660 |
Why?
| | Twins, Monozygotic | 1 | 2021 | 134 | 0.660 |
Why?
| | Diseases in Twins | 1 | 2021 | 115 | 0.650 |
Why?
| | Postoperative Complications | 19 | 2026 | 2919 | 0.650 |
Why?
| | Female | 87 | 2026 | 78271 | 0.640 |
Why?
| | Male | 87 | 2026 | 72315 | 0.630 |
Why?
| | Femur Head | 4 | 2025 | 39 | 0.620 |
Why?
| | Semicircular Canals | 1 | 2020 | 37 | 0.620 |
Why?
| | Femoracetabular Impingement | 5 | 2020 | 35 | 0.610 |
Why?
| | Cervical Vertebrae | 3 | 2026 | 158 | 0.600 |
Why?
| | Phospholipids | 1 | 2021 | 213 | 0.600 |
Why?
| | Retrospective Studies | 56 | 2026 | 17066 | 0.600 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2025 | 1720 | 0.560 |
Why?
| | Biomedical Research | 1 | 2025 | 710 | 0.560 |
Why?
| | Ultrasonography | 6 | 2022 | 770 | 0.550 |
Why?
| | Upper Extremity | 2 | 2023 | 112 | 0.540 |
Why?
| | Joint Instability | 6 | 2022 | 182 | 0.540 |
Why?
| | Surgeons | 1 | 2022 | 339 | 0.530 |
Why?
| | Case-Control Studies | 11 | 2026 | 3604 | 0.530 |
Why?
| | Health Status | 1 | 2023 | 836 | 0.520 |
Why?
| | Fracture Fixation | 3 | 2015 | 79 | 0.500 |
Why?
| | Algorithms | 2 | 2023 | 1837 | 0.480 |
Why?
| | Fracture Fixation, Intramedullary | 4 | 2022 | 60 | 0.480 |
Why?
| | Arteries | 1 | 2018 | 259 | 0.480 |
Why?
| | Femur | 5 | 2023 | 250 | 0.460 |
Why?
| | Tibial Fractures | 3 | 2023 | 72 | 0.460 |
Why?
| | Clavicle | 3 | 2014 | 38 | 0.450 |
Why?
| | Proprioception | 2 | 2026 | 34 | 0.430 |
Why?
| | Lower Extremity | 3 | 2023 | 438 | 0.400 |
Why?
| | Follow-Up Studies | 15 | 2026 | 5408 | 0.400 |
Why?
| | Neck Muscles | 2 | 2025 | 21 | 0.400 |
Why?
| | Anterior Cruciate Ligament Injuries | 4 | 2019 | 216 | 0.390 |
Why?
| | Treatment Outcome | 32 | 2026 | 11679 | 0.380 |
Why?
| | Magnetic Resonance Imaging | 7 | 2025 | 3863 | 0.380 |
Why?
| | Snow Sports | 1 | 2012 | 1 | 0.370 |
Why?
| | Oxylipins | 3 | 2023 | 47 | 0.370 |
Why?
| | Bias | 2 | 2025 | 202 | 0.360 |
Why?
| | Head Protective Devices | 1 | 2012 | 24 | 0.360 |
Why?
| | Femur Head Necrosis | 3 | 2016 | 15 | 0.360 |
Why?
| | Reoperation | 7 | 2024 | 630 | 0.360 |
Why?
| | Longitudinal Studies | 5 | 2026 | 2947 | 0.360 |
Why?
| | Fracture Fixation, Internal | 7 | 2022 | 207 | 0.350 |
Why?
| | Cohort Studies | 9 | 2026 | 5960 | 0.350 |
Why?
| | Patellofemoral Pain Syndrome | 1 | 2010 | 6 | 0.330 |
Why?
| | Pronation | 1 | 2010 | 10 | 0.320 |
Why?
| | Patellofemoral Joint | 1 | 2010 | 8 | 0.320 |
Why?
| | Epiphyses | 7 | 2021 | 25 | 0.320 |
Why?
| | Young Adult | 19 | 2026 | 14105 | 0.320 |
Why?
| | Bone Nails | 4 | 2019 | 62 | 0.310 |
Why?
| | Osteogenesis Imperfecta | 2 | 2020 | 14 | 0.310 |
Why?
| | Insulin | 2 | 2021 | 2507 | 0.310 |
Why?
| | Parent-Child Relations | 1 | 2012 | 270 | 0.290 |
Why?
| | Tomography, X-Ray Computed | 4 | 2025 | 2730 | 0.290 |
Why?
| | Imaging, Three-Dimensional | 2 | 2025 | 583 | 0.290 |
Why?
| | Manipulation, Orthopedic | 3 | 2019 | 8 | 0.290 |
Why?
| | Age of Onset | 3 | 2026 | 551 | 0.290 |
Why?
| | Severity of Illness Index | 7 | 2021 | 2925 | 0.280 |
Why?
| | Prognosis | 7 | 2026 | 4282 | 0.280 |
Why?
| | Radiation Dosage | 3 | 2025 | 192 | 0.270 |
Why?
| | Clubfoot | 2 | 2019 | 7 | 0.260 |
Why?
| | Casts, Surgical | 2 | 2019 | 35 | 0.260 |
Why?
| | Risk Factors | 17 | 2026 | 10779 | 0.260 |
Why?
| | Range of Motion, Articular | 8 | 2025 | 421 | 0.260 |
Why?
| | Knee Joint | 4 | 2025 | 426 | 0.260 |
Why?
| | Slipped Capital Femoral Epiphyses | 2 | 2018 | 7 | 0.250 |
Why?
| | Biomechanical Phenomena | 7 | 2025 | 842 | 0.250 |
Why?
| | Cadaver | 3 | 2022 | 304 | 0.240 |
Why?
| | Sports | 2 | 2022 | 211 | 0.240 |
Why?
| | Spine | 2 | 2018 | 182 | 0.240 |
Why?
| | Adult | 22 | 2026 | 40449 | 0.240 |
Why?
| | Surgical Wound Infection | 3 | 2018 | 316 | 0.230 |
Why?
| | Infant | 14 | 2025 | 10034 | 0.230 |
Why?
| | Head Movements | 1 | 2026 | 36 | 0.230 |
Why?
| | Arthrocentesis | 1 | 2025 | 11 | 0.230 |
Why?
| | Clinical Protocols | 2 | 2018 | 282 | 0.230 |
Why?
| | Prevalence | 4 | 2022 | 2834 | 0.230 |
Why?
| | Charcot-Marie-Tooth Disease | 2 | 2016 | 22 | 0.220 |
Why?
| | Depression | 2 | 2025 | 1558 | 0.220 |
Why?
| | Muscle, Skeletal | 2 | 2025 | 1795 | 0.220 |
Why?
| | Time Factors | 14 | 2025 | 7173 | 0.220 |
Why?
| | Athletes | 5 | 2022 | 419 | 0.220 |
Why?
| | Knee | 1 | 2025 | 71 | 0.220 |
Why?
| | Genetic Predisposition to Disease | 3 | 2023 | 2363 | 0.220 |
Why?
| | Tibia | 2 | 2023 | 176 | 0.210 |
Why?
| | Tibial Meniscus Injuries | 2 | 2015 | 62 | 0.210 |
Why?
| | Elbow Joint | 3 | 2019 | 74 | 0.210 |
Why?
| | Sternoclavicular Joint | 2 | 2014 | 13 | 0.210 |
Why?
| | Cartilage, Articular | 2 | 2020 | 343 | 0.200 |
Why?
| | Odds Ratio | 8 | 2019 | 1075 | 0.200 |
Why?
| | Walking | 2 | 2025 | 545 | 0.200 |
Why?
| | Orthotic Devices | 3 | 2022 | 26 | 0.200 |
Why?
| | Dizziness | 1 | 2024 | 101 | 0.200 |
Why?
| | Radiation Exposure | 1 | 2024 | 63 | 0.200 |
Why?
| | HLA-DR4 Antigen | 2 | 2021 | 74 | 0.200 |
Why?
| | HLA-DR3 Antigen | 2 | 2021 | 76 | 0.200 |
Why?
| | Humerus | 2 | 2022 | 39 | 0.190 |
Why?
| | Growth Plate | 2 | 2023 | 39 | 0.190 |
Why?
| | Meniere Disease | 1 | 2023 | 36 | 0.190 |
Why?
| | Spinal Fractures | 1 | 2023 | 73 | 0.190 |
Why?
| | Prospective Studies | 10 | 2026 | 7990 | 0.180 |
Why?
| | Ligaments, Articular | 1 | 2022 | 54 | 0.180 |
Why?
| | Hip Fractures | 1 | 2023 | 84 | 0.180 |
Why?
| | Gait Disorders, Neurologic | 1 | 2022 | 45 | 0.180 |
Why?
| | Wrist Joint | 1 | 2022 | 71 | 0.180 |
Why?
| | Ankle Fractures | 1 | 2022 | 19 | 0.180 |
Why?
| | Deafness | 1 | 2023 | 78 | 0.180 |
Why?
| | Quadriceps Muscle | 3 | 2022 | 118 | 0.180 |
Why?
| | Orthopedic Surgeons | 1 | 2022 | 30 | 0.180 |
Why?
| | Legg-Calve-Perthes Disease | 1 | 2021 | 4 | 0.170 |
Why?
| | Radius Fractures | 1 | 2022 | 69 | 0.170 |
Why?
| | Bone Plates | 2 | 2022 | 80 | 0.170 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2021 | 49 | 0.170 |
Why?
| | Sleep Wake Disorders | 1 | 2025 | 301 | 0.170 |
Why?
| | Selection Bias | 1 | 2021 | 38 | 0.170 |
Why?
| | Migraine Disorders | 1 | 2023 | 112 | 0.170 |
Why?
| | Orthognathic Surgical Procedures | 1 | 2001 | 6 | 0.170 |
Why?
| | Age Factors | 7 | 2021 | 3333 | 0.170 |
Why?
| | Pelvic Bones | 1 | 2023 | 135 | 0.170 |
Why?
| | Prosthesis Fitting | 1 | 2020 | 14 | 0.160 |
Why?
| | Incidence | 8 | 2023 | 2879 | 0.160 |
Why?
| | B-Lymphocytes | 1 | 2026 | 876 | 0.160 |
Why?
| | Lumbar Vertebrae | 1 | 2022 | 252 | 0.160 |
Why?
| | Probability | 1 | 2021 | 310 | 0.160 |
Why?
| | Suture Techniques | 2 | 2019 | 131 | 0.160 |
Why?
| | Arthralgia | 2 | 2020 | 61 | 0.160 |
Why?
| | Monitoring, Intraoperative | 2 | 2016 | 64 | 0.160 |
Why?
| | Cerebral Palsy | 1 | 2022 | 132 | 0.160 |
Why?
| | Neutrophils | 1 | 2026 | 1134 | 0.160 |
Why?
| | Muscle Strength | 2 | 2021 | 330 | 0.150 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 149 | 0.150 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1325 | 0.150 |
Why?
| | Recreation | 1 | 2019 | 27 | 0.150 |
Why?
| | Patella | 1 | 2019 | 28 | 0.150 |
Why?
| | Play and Playthings | 1 | 2019 | 35 | 0.150 |
Why?
| | Intraoperative Complications | 1 | 2001 | 155 | 0.150 |
Why?
| | Histology | 1 | 2019 | 4 | 0.150 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2019 | 13 | 0.150 |
Why?
| | Education, Professional | 1 | 2019 | 18 | 0.140 |
Why?
| | Equipment Failure | 1 | 2019 | 115 | 0.140 |
Why?
| | Research Design | 1 | 2025 | 1135 | 0.140 |
Why?
| | Gene Frequency | 1 | 2020 | 481 | 0.140 |
Why?
| | Health Occupations | 1 | 2019 | 36 | 0.140 |
Why?
| | Quality Improvement | 2 | 2025 | 1289 | 0.140 |
Why?
| | Tendons | 1 | 2019 | 129 | 0.140 |
Why?
| | Computer-Assisted Instruction | 1 | 2019 | 71 | 0.140 |
Why?
| | Interleukins | 1 | 2020 | 248 | 0.140 |
Why?
| | Smoking | 1 | 2025 | 1472 | 0.140 |
Why?
| | Logistic Models | 5 | 2017 | 2117 | 0.140 |
Why?
| | Genetic Association Studies | 1 | 2020 | 372 | 0.140 |
Why?
| | Pattern Recognition, Visual | 1 | 2019 | 105 | 0.140 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2018 | 16 | 0.140 |
Why?
| | Prader-Willi Syndrome | 1 | 2018 | 31 | 0.140 |
Why?
| | Anesthesia, Local | 1 | 2018 | 25 | 0.130 |
Why?
| | Femoral Nerve | 1 | 2018 | 21 | 0.130 |
Why?
| | Bone Malalignment | 1 | 2017 | 12 | 0.130 |
Why?
| | Meningomyelocele | 1 | 2018 | 61 | 0.130 |
Why?
| | CpG Islands | 3 | 2023 | 165 | 0.130 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 374 | 0.130 |
Why?
| | Sciatic Nerve | 1 | 2018 | 59 | 0.130 |
Why?
| | Analgesia, Epidural | 1 | 2018 | 38 | 0.130 |
Why?
| | Collagen | 1 | 2020 | 456 | 0.130 |
Why?
| | Arthroscopy | 2 | 2020 | 267 | 0.130 |
Why?
| | Femoral Fractures | 1 | 2018 | 82 | 0.130 |
Why?
| | Antibiotic Prophylaxis | 1 | 2018 | 129 | 0.130 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 442 | 0.120 |
Why?
| | Cumulative Trauma Disorders | 1 | 2016 | 30 | 0.120 |
Why?
| | Learning Curve | 1 | 2017 | 70 | 0.120 |
Why?
| | Epiphyses, Slipped | 1 | 2016 | 6 | 0.120 |
Why?
| | Nerve Block | 1 | 2018 | 103 | 0.120 |
Why?
| | Open Fracture Reduction | 1 | 2016 | 30 | 0.120 |
Why?
| | Immunity, Innate | 1 | 2022 | 846 | 0.120 |
Why?
| | Pain | 1 | 2022 | 779 | 0.120 |
Why?
| | ST Elevation Myocardial Infarction | 1 | 2016 | 63 | 0.120 |
Why?
| | Substance-Related Disorders | 1 | 2025 | 1094 | 0.110 |
Why?
| | Electrocardiography | 2 | 2016 | 662 | 0.110 |
Why?
| | Postoperative Hemorrhage | 1 | 2016 | 104 | 0.110 |
Why?
| | Metabolomics | 1 | 2021 | 727 | 0.110 |
Why?
| | Shoulder Fractures | 1 | 2015 | 14 | 0.110 |
Why?
| | Radius | 1 | 2015 | 52 | 0.110 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5868 | 0.110 |
Why?
| | Nonprescription Drugs | 1 | 2015 | 65 | 0.110 |
Why?
| | Predictive Value of Tests | 5 | 2020 | 2115 | 0.110 |
Why?
| | Forecasting | 1 | 2016 | 391 | 0.110 |
Why?
| | Soft Tissue Injuries | 1 | 2015 | 34 | 0.110 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2014 | 36 | 0.110 |
Why?
| | Unnecessary Procedures | 1 | 2015 | 53 | 0.110 |
Why?
| | Bone Marrow Transplantation | 1 | 2015 | 294 | 0.110 |
Why?
| | Autografts | 1 | 2014 | 55 | 0.110 |
Why?
| | Menisci, Tibial | 1 | 2014 | 78 | 0.100 |
Why?
| | Long QT Syndrome | 1 | 2015 | 69 | 0.100 |
Why?
| | Elective Surgical Procedures | 1 | 2016 | 201 | 0.100 |
Why?
| | Bone Diseases | 1 | 2014 | 61 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 2 | 2015 | 1356 | 0.100 |
Why?
| | United States | 10 | 2025 | 15966 | 0.100 |
Why?
| | Prescription Drugs | 1 | 2015 | 111 | 0.100 |
Why?
| | Diet | 1 | 2021 | 1273 | 0.100 |
Why?
| | Patient Compliance | 1 | 2018 | 588 | 0.100 |
Why?
| | Allografts | 1 | 2014 | 150 | 0.100 |
Why?
| | Venous Thrombosis | 1 | 2016 | 194 | 0.100 |
Why?
| | Joint Dislocations | 1 | 2014 | 60 | 0.100 |
Why?
| | Cartilage | 1 | 2015 | 198 | 0.100 |
Why?
| | Pulmonary Embolism | 1 | 2016 | 244 | 0.100 |
Why?
| | Risk Assessment | 7 | 2017 | 3671 | 0.100 |
Why?
| | Obesity | 3 | 2015 | 3077 | 0.100 |
Why?
| | Shoulder Dislocation | 1 | 2014 | 61 | 0.100 |
Why?
| | Chi-Square Distribution | 4 | 2015 | 529 | 0.100 |
Why?
| | Injury Severity Score | 3 | 2023 | 600 | 0.100 |
Why?
| | Caregivers | 1 | 2022 | 1049 | 0.090 |
Why?
| | Exercise | 1 | 2025 | 2201 | 0.090 |
Why?
| | Intra-Articular Fractures | 1 | 2012 | 19 | 0.090 |
Why?
| | Bupivacaine | 1 | 2012 | 38 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2145 | 0.090 |
Why?
| | Body Mass Index | 3 | 2016 | 2438 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 4 | 2016 | 965 | 0.090 |
Why?
| | Amides | 1 | 2012 | 101 | 0.090 |
Why?
| | Pediatrics | 1 | 2020 | 1114 | 0.090 |
Why?
| | Bone and Bones | 1 | 2014 | 314 | 0.090 |
Why?
| | Multivariate Analysis | 4 | 2017 | 1539 | 0.090 |
Why?
| | Clinical Competence | 2 | 2017 | 1244 | 0.090 |
Why?
| | Graft Survival | 1 | 2014 | 526 | 0.090 |
Why?
| | Treatment Failure | 3 | 2019 | 365 | 0.090 |
Why?
| | Anemia, Sickle Cell | 1 | 2015 | 312 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2023 | 2583 | 0.080 |
Why?
| | Linear Models | 3 | 2021 | 854 | 0.080 |
Why?
| | Guideline Adherence | 1 | 2015 | 589 | 0.080 |
Why?
| | Operative Time | 3 | 2017 | 175 | 0.080 |
Why?
| | Recovery of Function | 4 | 2016 | 707 | 0.080 |
Why?
| | Gait | 2 | 2025 | 313 | 0.080 |
Why?
| | Reproducibility of Results | 4 | 2020 | 3409 | 0.080 |
Why?
| | Craniocerebral Trauma | 1 | 2012 | 176 | 0.080 |
Why?
| | North America | 1 | 2011 | 310 | 0.080 |
Why?
| | Data Collection | 1 | 2012 | 633 | 0.070 |
Why?
| | Aged, 80 and over | 2 | 2021 | 8265 | 0.070 |
Why?
| | Torque | 2 | 2021 | 81 | 0.070 |
Why?
| | Emergency Medical Services | 1 | 2016 | 696 | 0.070 |
Why?
| | Trauma Centers | 2 | 2022 | 462 | 0.070 |
Why?
| | Sex Factors | 3 | 2021 | 2112 | 0.070 |
Why?
| | Health Care Surveys | 1 | 2011 | 539 | 0.070 |
Why?
| | Analgesics, Opioid | 1 | 2018 | 1143 | 0.070 |
Why?
| | Facial Bones | 2 | 2001 | 28 | 0.070 |
Why?
| | Mice | 2 | 2023 | 18339 | 0.070 |
Why?
| | Neuromuscular Diseases | 1 | 2010 | 146 | 0.070 |
Why?
| | Databases, Factual | 2 | 2026 | 1486 | 0.070 |
Why?
| | Equipment Failure Analysis | 2 | 2020 | 128 | 0.070 |
Why?
| | Postoperative Care | 3 | 2015 | 288 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1907 | 0.060 |
Why?
| | Observer Variation | 2 | 2018 | 355 | 0.060 |
Why?
| | Regression Analysis | 2 | 2019 | 1003 | 0.060 |
Why?
| | Bone Transplantation | 2 | 2019 | 86 | 0.060 |
Why?
| | Self Report | 2 | 2025 | 872 | 0.060 |
Why?
| | Hospitals, Pediatric | 2 | 2025 | 556 | 0.060 |
Why?
| | Vestibular Function Tests | 1 | 2026 | 41 | 0.060 |
Why?
| | Equipment Design | 2 | 2019 | 530 | 0.060 |
Why?
| | Hemodilution | 2 | 1996 | 11 | 0.060 |
Why?
| | Reflex, Vestibulo-Ocular | 1 | 2026 | 31 | 0.060 |
Why?
| | Middle Aged | 8 | 2025 | 35875 | 0.060 |
Why?
| | Arthritis, Infectious | 1 | 2025 | 72 | 0.050 |
Why?
| | Tertiary Care Centers | 1 | 2025 | 189 | 0.050 |
Why?
| | Patient Care Team | 1 | 2010 | 689 | 0.050 |
Why?
| | Infant, Newborn | 4 | 2019 | 6429 | 0.050 |
Why?
| | Knee Injuries | 2 | 2015 | 122 | 0.050 |
Why?
| | Fluoroscopy | 1 | 2024 | 176 | 0.050 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 82 | 0.050 |
Why?
| | Animals | 2 | 2023 | 38058 | 0.050 |
Why?
| | X-Rays | 1 | 2022 | 31 | 0.050 |
Why?
| | Reaction Time | 1 | 2025 | 438 | 0.050 |
Why?
| | Electromyography | 1 | 2025 | 415 | 0.050 |
Why?
| | Pain Measurement | 2 | 2018 | 552 | 0.050 |
Why?
| | Vestibule, Labyrinth | 1 | 2024 | 91 | 0.050 |
Why?
| | Operating Rooms | 1 | 2024 | 146 | 0.050 |
Why?
| | Vertigo | 1 | 2023 | 55 | 0.050 |
Why?
| | Colorado | 3 | 2018 | 4564 | 0.050 |
Why?
| | Patient Satisfaction | 2 | 2018 | 704 | 0.040 |
Why?
| | Pelvis | 1 | 2023 | 124 | 0.040 |
Why?
| | Physical Therapy Modalities | 2 | 2015 | 332 | 0.040 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 158 | 0.040 |
Why?
| | Anatomic Variation | 1 | 2021 | 4 | 0.040 |
Why?
| | Ascorbic Acid | 1 | 2023 | 180 | 0.040 |
Why?
| | Fracture Healing | 1 | 2022 | 90 | 0.040 |
Why?
| | Peripheral Nerves | 1 | 2022 | 72 | 0.040 |
Why?
| | Catheters | 1 | 2022 | 75 | 0.040 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 68 | 0.040 |
Why?
| | Standard of Care | 1 | 2022 | 80 | 0.040 |
Why?
| | Osteotomy, Le Fort | 1 | 2001 | 2 | 0.040 |
Why?
| | Preanesthetic Medication | 1 | 2001 | 6 | 0.040 |
Why?
| | Chin | 1 | 2001 | 8 | 0.040 |
Why?
| | Malocclusion | 1 | 2001 | 21 | 0.040 |
Why?
| | Pulmonary Atelectasis | 1 | 2001 | 16 | 0.040 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2021 | 54 | 0.040 |
Why?
| | Linoleic Acid | 1 | 2021 | 44 | 0.040 |
Why?
| | Muscle Strength Dynamometer | 1 | 2021 | 23 | 0.040 |
Why?
| | Arachidonic Acid | 1 | 2021 | 101 | 0.040 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2001 | 25 | 0.040 |
Why?
| | Work | 1 | 2020 | 23 | 0.040 |
Why?
| | Musculoskeletal System | 1 | 2021 | 49 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 2021 | 165 | 0.040 |
Why?
| | Osteogenesis, Distraction | 1 | 2001 | 25 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2021 | 83 | 0.040 |
Why?
| | Blood | 1 | 2001 | 109 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 48 | 0.040 |
Why?
| | Anesthesia, General | 1 | 2001 | 118 | 0.040 |
Why?
| | Patellar Ligament | 1 | 2019 | 26 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2001 | 107 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 592 | 0.040 |
Why?
| | Functional Laterality | 1 | 2020 | 241 | 0.040 |
Why?
| | Educational Status | 1 | 2022 | 467 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 758 | 0.040 |
Why?
| | Athletic Performance | 1 | 2020 | 76 | 0.040 |
Why?
| | Epidemiological Monitoring | 1 | 2019 | 69 | 0.040 |
Why?
| | Fetal Blood | 1 | 2021 | 342 | 0.040 |
Why?
| | Emergency Service, Hospital | 2 | 2023 | 2310 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 142 | 0.040 |
Why?
| | Sutures | 1 | 2019 | 64 | 0.040 |
Why?
| | Students | 1 | 2025 | 663 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 594 | 0.040 |
Why?
| | Isometric Contraction | 1 | 2021 | 188 | 0.040 |
Why?
| | Ligaments | 1 | 2019 | 75 | 0.040 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2025 | 675 | 0.040 |
Why?
| | Students, Health Occupations | 1 | 2019 | 37 | 0.030 |
Why?
| | Anterior Cruciate Ligament | 1 | 2019 | 101 | 0.030 |
Why?
| | Eye Movements | 1 | 2019 | 92 | 0.030 |
Why?
| | Professional Competence | 1 | 2019 | 98 | 0.030 |
Why?
| | Hospitals | 1 | 2023 | 730 | 0.030 |
Why?
| | Random Allocation | 1 | 2019 | 363 | 0.030 |
Why?
| | Comorbidity | 2 | 2015 | 1658 | 0.030 |
Why?
| | Anxiety | 1 | 2025 | 1109 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 576 | 0.030 |
Why?
| | Video Recording | 1 | 2019 | 212 | 0.030 |
Why?
| | Breast Feeding | 1 | 2021 | 448 | 0.030 |
Why?
| | Thoracic Vertebrae | 1 | 2018 | 79 | 0.030 |
Why?
| | Risk Management | 1 | 2018 | 84 | 0.030 |
Why?
| | Calcium | 1 | 2023 | 1183 | 0.030 |
Why?
| | Organ Size | 1 | 2018 | 463 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2018 | 249 | 0.030 |
Why?
| | Device Removal | 1 | 2018 | 143 | 0.030 |
Why?
| | Ileostomy | 1 | 1996 | 25 | 0.030 |
Why?
| | Intestinal Fistula | 1 | 1996 | 17 | 0.030 |
Why?
| | Ribs | 1 | 2015 | 35 | 0.030 |
Why?
| | Inservice Training | 1 | 2016 | 117 | 0.030 |
Why?
| | Methylprednisolone | 1 | 1996 | 64 | 0.030 |
Why?
| | Patient Outcome Assessment | 1 | 2016 | 134 | 0.030 |
Why?
| | Missouri | 1 | 2015 | 66 | 0.030 |
Why?
| | Intracranial Pressure | 1 | 2016 | 65 | 0.030 |
Why?
| | Postoperative Period | 1 | 2016 | 354 | 0.030 |
Why?
| | Area Under Curve | 1 | 2016 | 330 | 0.030 |
Why?
| | Intestinal Obstruction | 1 | 1996 | 56 | 0.030 |
Why?
| | Matched-Pair Analysis | 1 | 2015 | 37 | 0.030 |
Why?
| | Titanium | 1 | 2015 | 81 | 0.030 |
Why?
| | Radiologic Health | 1 | 2015 | 4 | 0.030 |
Why?
| | Curettage | 1 | 2014 | 8 | 0.030 |
Why?
| | Esthetics | 1 | 2015 | 41 | 0.030 |
Why?
| | Rotation | 1 | 2015 | 121 | 0.030 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 1560 | 0.030 |
Why?
| | Medical Records | 1 | 2015 | 187 | 0.030 |
Why?
| | Lysholm Knee Score | 1 | 2014 | 8 | 0.030 |
Why?
| | Trauma Severity Indices | 1 | 2015 | 112 | 0.030 |
Why?
| | Biomarkers | 1 | 2026 | 4271 | 0.030 |
Why?
| | Transplantation, Autologous | 1 | 2015 | 290 | 0.030 |
Why?
| | Skull | 1 | 1996 | 158 | 0.030 |
Why?
| | Cost Savings | 1 | 2015 | 86 | 0.030 |
Why?
| | Edema | 1 | 1995 | 124 | 0.030 |
Why?
| | Coxa Valga | 1 | 2014 | 1 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 614 | 0.030 |
Why?
| | Physical Examination | 1 | 2015 | 239 | 0.030 |
Why?
| | Finite Element Analysis | 1 | 2014 | 67 | 0.030 |
Why?
| | Immobilization | 1 | 2014 | 53 | 0.030 |
Why?
| | Age Distribution | 1 | 2015 | 403 | 0.030 |
Why?
| | Regional Blood Flow | 1 | 2016 | 514 | 0.030 |
Why?
| | Sex Distribution | 1 | 2015 | 386 | 0.030 |
Why?
| | Pain Management | 1 | 2018 | 405 | 0.030 |
Why?
| | Face | 1 | 1995 | 173 | 0.020 |
Why?
| | Osteoarthritis, Hip | 1 | 2014 | 45 | 0.020 |
Why?
| | Occupational Therapy | 1 | 2015 | 111 | 0.020 |
Why?
| | Preoperative Care | 1 | 2015 | 379 | 0.020 |
Why?
| | Injections, Intra-Articular | 1 | 2012 | 58 | 0.020 |
Why?
| | Hospitalization | 1 | 2023 | 2433 | 0.020 |
Why?
| | Pregnancy | 1 | 2025 | 7190 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 1996 | 474 | 0.020 |
Why?
| | Anesthetics, Local | 1 | 2012 | 100 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2012 | 312 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1075 | 0.020 |
Why?
| | Disease Management | 1 | 2015 | 645 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 779 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 3185 | 0.020 |
Why?
| | Communication | 1 | 2016 | 965 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1306 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2027 | 0.020 |
Why?
| | Lung | 1 | 2001 | 4109 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 6048 | 0.010 |
Why?
| | Acute-Phase Proteins | 2 | 1996 | 67 | 0.010 |
Why?
| | Aged | 2 | 2022 | 25913 | 0.010 |
Why?
| | Length of Stay | 1 | 2010 | 1337 | 0.010 |
Why?
| | Inflammation | 1 | 1996 | 2878 | 0.010 |
Why?
| | Critical Care | 1 | 2010 | 695 | 0.010 |
Why?
| | Orosomucoid | 1 | 1995 | 9 | 0.010 |
Why?
| | Telemetry | 1 | 1995 | 41 | 0.010 |
Why?
| | Blood Volume | 1 | 1995 | 65 | 0.010 |
Why?
| | Hematocrit | 1 | 1995 | 108 | 0.010 |
Why?
| | Morbidity | 1 | 1996 | 323 | 0.010 |
Why?
| | Mandible | 1 | 1995 | 72 | 0.010 |
Why?
| | Haptoglobins | 1 | 1995 | 66 | 0.010 |
Why?
| | Rectal Neoplasms | 1 | 1996 | 156 | 0.010 |
Why?
| | Colitis, Ulcerative | 1 | 1996 | 147 | 0.010 |
Why?
| | Fibrinogen | 1 | 1995 | 177 | 0.010 |
Why?
| | C-Reactive Protein | 1 | 1995 | 416 | 0.010 |
Why?
| | Crohn Disease | 1 | 1996 | 260 | 0.010 |
Why?
|
|
Carry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|